HPS Pharmacies wish to advise that Pfizer is experiencing a supply interruption for heparin as follows:

Heparin Sodium
Heparin sodium 25,000IU/5mL
ARTG 49236

This supply interruption is expected to be resolved by the end of December 2024.

An internationally registered alternative has been approved for supply under Section 19A of the Therapeutic Goods Act 1989. The alternative product is also preservative-free, and all packaging is in English.

Heparin is a high-risk medication. Additional care is recommended when selecting products, particularly when the packaging may be unfamiliar. The following table compares the Australian-registered product with the S19A alternative.

  Heparin sodium 25000IU/5mL (Pfizer) Heparin sodium (Wockhardt) preservative-free
Product type Australian registered S19A
Excipients Water for injection
  • Water for injections
  • Sodium hydroxide solution 3M
  • Hydrochloric acid 3M
Pack size 50 Steriluer ampoules 10 neutral glass ampoules
Storage < 25°C Do not store > 25°C
Store in original package
Additional information Single-use only Single-use only

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact Pfizer on 1800 675 229 or your pharmacist at HPS Pharmacies.

Download PDF

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates